• EN

Table PDU-6. Estimated trends in the prevalence of problem and injecting drug use, 2006–11 (rate per 1 000 population aged 15–64): Combined estimates per country

Part (iv) Estimated trends of problem stimulant use

Country200620072008200920102011Drug use [1]Method [1]
Czech Republic2.692.842.873.413.814.24PSUTM


Data represents a selection based on the availability of the same calculation method over the time. In some countries more estimates might be available. The selection was made in order for the trend to be unbiased. In some countries data are insufficient to report.

Target groups may vary between countries owing to different methods and data sources; therefore comparisons should be made with caution.

For more details see Tables PDU-1, PDU-102 and PDU-103 in the Statistical bulletin 2013.

See also ‘General notes for interpreting data’ on the Explanatory notes and help page

See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich.

[1] - POU = Problem opioid use; PSU = Problem stimulant use; IDU = Injecting drug use; PDU = Problem drug use. TM = Treatment Multiplier ; HM = HIV Multiplier ; MM = Mortality Multiplier ; MI = Multivariate Indicator Method ; PM = Police Multiplier ; TP = Truncated Poisson ; CM = Combined Methods. CR = Capture Recapture, OT = Other Methods.


Reitox national focal points

2013 REITOX National Reports - Fonte PDU template

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013